| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,976 |
4,511 |
$55K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,829 |
3,732 |
$51K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,586 |
2,677 |
$45K |
| 99215 |
Prolong outpt/office vis |
1,594 |
1,579 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,535 |
1,239 |
$18K |
| 99483 |
Prolong outpt/office vis |
128 |
126 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,340 |
2,208 |
$10K |
| 1090F |
|
5,906 |
4,959 |
$8K |
| 76770 |
|
531 |
528 |
$7K |
| 81002 |
|
6,497 |
5,901 |
$7K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,520 |
2,627 |
$4K |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
270 |
264 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
1,102 |
1,085 |
$3K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
398 |
398 |
$3K |
| 3017F |
|
8,065 |
6,706 |
$2K |
| 3044F |
|
4,144 |
3,512 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,102 |
1,079 |
$2K |
| G0180 |
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
104 |
104 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
233 |
232 |
$700.00 |
| 93000 |
|
26 |
26 |
$237.04 |
| 69210 |
|
25 |
25 |
$213.50 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
4,244 |
3,515 |
$206.48 |
| 3045F |
|
226 |
202 |
$190.22 |
| 64566 |
|
34 |
25 |
$105.89 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
13 |
$62.70 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,924 |
4,046 |
$27.88 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
8,313 |
6,920 |
$4.26 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
8,347 |
6,937 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
723 |
640 |
$0.00 |
| 4086F |
|
43 |
39 |
$0.00 |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
1,932 |
1,690 |
$0.00 |
| G8399 |
Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed |
2,142 |
1,853 |
$0.00 |
| 90756 |
|
28 |
28 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
26 |
26 |
$0.00 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
186 |
185 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
104 |
52 |
$0.00 |
| G8400 |
Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given |
39 |
38 |
$0.00 |
| G9900 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified |
17 |
16 |
$0.00 |
| M1189 |
Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed |
41 |
37 |
$0.00 |
| 1124F |
|
42 |
38 |
$0.00 |